Industrial sterilization and cleaning company Mork Process Inc. has raised $1.4 million in equity of an expected $2 million funding round, according to a regulatory filing.
The Stow, Ohio-based company specializes in process cleaning and sterilizing equipment for manufacturers in the pharmaceutical, biotechnology and food industries. It’s specialty is “clean-in-place” and “sterilize-in-place” technologies used to sterilize the inside of large mixing containers.
The funding comes as the company hired a new chief executive, Chris Yessayan, a former executive with home health equipment maker Invacare Corp. Yessayan was traveling and not available for comment.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In 2008, Mork raised a $3 million Series A round that was led by Mutual Capital Partners in Cleveland and Reservoir Venture Partners in Columbus.
The latest bit of funding comes from 11 investors, with the first sale occurring on June 28, according to the document.
Mork was founded in Denmark in 1996 with a focus on the pharmaceutical industry and established U.S. operations in 2002.
